01Factory Overview

• 

  Your End-to-End Microbial-Based
  Biopharmaceutical CMO Partner

  As A Fully Integrated Contract Manufacturing Organization (CMO), We Specialize In Microbial-Based Biopharmaceuticals. In 2024, We Opened Our Cutting-Edge Manufacturing Plant At The Hyangnam Campus In South Korea, Offering End-To-End CMO Services Under ONE ROOF. Our State-Of-The-Art Facility Is Designed To Meet The Evolving Needs Of Our Clients From Pilot Scale Clinical Production To Commercial Scale Manufacturing While Maintaining Full Compliance With Global CGMP Standards.

• Drug Substance(DS)
  Manufacturing

  Fermentation capacity:
  Up to 900 liters working volume
  Designed for microbial-based
  biologics production

  
• 

  Drug Product(DP)
  Manufacturing

  Capable of producing
  multiple dosage forms:
  
  Liquid vials, Lyophilized vials,
  Cartridges, Pre-filled syringes,
  Sprays